KEMTA masterclass: Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
-
Masterclass
Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
By: Sabine Grimm/Bram Ramaekers
Language: English
The masterclasses will take place via Teams of Zoom. You can register by sending an e-mail to: Irene.vrancken@mumc.nl.
KEMTA (Clinical Epidemiology & Medical Technology Assessment) of MUMC+ regularly organises masterclasses for employees interested in research methods. The masterclasses give short insights into a variety of topics, from the basics of setting up research to statistics and hot topics such as early HTA.
Also read
-
PhD defence Hamza Khan
" Privacy-Compliant Data Handling and Predictive Modelling in Multiple Sclerosis"1 Dec -
PhD defence Anouk Boonstra
" Timely, Transdiagnostic & Tailored to Youth The necessity and (cost-)effectiveness of accessible youth mental health interventions"1 Dec -
PhD defence Maggie Han
" Physical Activity and Sleep Monitoring Using Wearable Devices in Patients on Hemodialysis"1 Dec